Doxycycline Delayed-Release Tablets Suppliers & Bulk Manufacturers
Available Forms: Doxycycline Delayed-Release Tablets
Available Strengths: 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025
Reference Brands: Vibramycin (US & EU)
Category: Antibiotics
Doxycycline delayed-release tablets and capsules inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA attachment. They provide sustained, effective antimicrobial action with fewer gastrointestinal side effects, making them suitable for long-term treatment of respiratory, urinary, and skin infections, with benefits including improved compliance and consistent drug levels.
Product Description:
Doxycycline delayed-release tablets and capsules are approved in the EU and US for treating respiratory, urinary, and skin infections. In the EU, brands like Vibramycin XR are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for doxycycline XR formulations, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Doxycycline Delayed-Release Tablets — third party manufacturing & bulk supply
Doxycycline Delayed-Release Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Doxycycline Delayed-Release Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Doxycycline Delayed-Release Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Doxycycline Delayed-Release Tablets are used to treat a variety of bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, acne, sexually transmitted infections, and certain vector-borne diseases such as Lyme disease and malaria. The delayed-release formulation allows the medicine to be released slowly in the body, helping improve tolerability and maintaining effective drug levels.
Doxycycline Delayed-Release Tablets are made from the active pharmaceutical ingredient doxycycline hyclate, a semi-synthetic tetracycline antibiotic derived from oxytetracycline. The delayed-release technology controls how the drug dissolves and is absorbed in the gastrointestinal tract.
Doxycycline Delayed-Release Tablets are marketed under trade names such as Doryx, Doryx MPC, Vibramycin, and other generic doxycycline delayed-release brands depending on the manufacturer and region.
One of the well-known delayed-release doxycycline brands, Doryx, has been marketed by Mayne Pharma. Other companies including Teva Pharmaceutical Industries and Mylan also manufacture generic versions of doxycycline delayed-release tablets.
The generic name of Doxycycline Delayed-Release Tablets is doxycycline hyclate.
Common brand names include Doryx, Doryx MPC, Vibramycin, and other doxycycline delayed-release tablet brands depending on the manufacturer.
Doxycycline Delayed-Release Tablets are manufactured in multiple countries including the United States, India, China, and several European countries by different pharmaceutical manufacturers supplying global markets.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
